Brad Margus has been tapped to co-chair the oversight board for the Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a new, innovative program at the National Institutes of Health.
NeuroNEXT, will provide a robust, standardized, and expert network of 25 clinical centers across the USA to more quickly test treatments for adults and children with neurological disorders. It promises to alleviate some of the current bottlenecks in the development of new drugs for neurological disorders and could be useful to test promising therapies for A-T.
Oops! We could not locate your form.